AAAAAA
Results:
1-7
|
Results: 7
Authors:
SWAN SK
LAMBRECHT L
ANJUM S
MACRES M
MATHUR VS
FELLMANN J
LUTHER RR
EPSTEIN M
Citation: Sk. Swan et al., RENAL EFFECTS OF FENOLDOPAM (F), A NOVEL PARENTERAL ANTIHYPERTENSIVE,IN NORMOTENSIVE SUBJECTS, Journal of the American Society of Nephrology, 8, 1997, pp. 1485-1485
Authors:
GOERDT PJ
HEIMDUTHOY KL
MACRES M
SWAN SK
Citation: Pj. Goerdt et al., PREDICTIVE PERFORMANCE OF RENAL-FUNCTION ESTIMATE EQUATIONS IN RENAL-ALLOGRAFTS, British journal of clinical pharmacology, 44(3), 1997, pp. 261-265
Authors:
SWAN SK
LAMBRECHT LJ
STPETER JV
MACRES M
SCHWARZ R
HURSTING M
Citation: Sk. Swan et al., PHARMACOLOGICAL PROFILE OF ARGATROBAN (ARG), A THROMBIN INHIBITOR, INHUMANS WITH IMPAIRED RENAL-FUNCTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 85-85
Authors:
LAMBRECHT LJ
SWAN SK
CUTLER DL
AFFRIME MB
RADWANSKI E
BATRA V
MACRES M
Citation: Lj. Lambrecht et al., DISPOSITION OF RECOMBINANT HUMAN INTERLEUKIN-10 (IL-10) IN PATIENTS WITH VARIOUS DEGREES OF RENAL-FUNCTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 87-87
Authors:
BREEN GA
STPETER JV
MACRES M
SWAN SK
Citation: Ga. Breen et al., PREDICTING CREATININE CLEARANCE (CLCR) IN DIABETIC (DM) AND RENAL-TRANSPLANT (TX) PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 683-683
Authors:
SWAN SK
LAMBRECHT LJ
STPETER JV
MACRES M
SCHWARZ R
Citation: Sk. Swan et al., PHARMACOLOGICAL PROFILE OF ARGATROBAN, A THROMBIN INHIBITOR, IN HUMANS WITH IMPAIRED RENAL-FUNCTION, Journal of the American Society of Nephrology, 7(9), 1996, pp. 769-769
Authors:
STPETER WL
LAMBRECHT LJ
MACRES M
Citation: Wl. Stpeter et al., RANDOMIZED CROSS-OVER STUDY OF ADVERSE REACTIONS AND COST IMPLICATIONS OF INTRAVENOUS PUSH COMPARED WITH INFUSION OF IRON DEXTRAN IN HEMODIALYSIS-PATIENTS, American journal of kidney diseases, 28(4), 1996, pp. 523-528
Risultati:
1-7
|